These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35151691)

  • 1. Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection.
    Silva RP; DiVenere AM; Amengor D; Maynard JA
    J Biol Chem; 2022 Mar; 298(3):101715. PubMed ID: 35151691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
    Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA
    Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
    Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
    DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
    mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine.
    da Silva FR; Napoleão-Pego P; De-Simone SG
    Vaccine; 2014 Oct; 32(47):6251-8. PubMed ID: 25252193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin.
    Hijnen M; He Q; Schepp R; Van Gageldonk P; Mertsola J; Mooi FR; Berbers GA
    Scand J Infect Dis; 2008; 40(2):94-104. PubMed ID: 17926203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition.
    Hijnen M; de Voer R; Mooi FR; Schepp R; Moret EE; van Gageldonk P; Smits G; Berbers GA
    Vaccine; 2007 Aug; 25(31):5902-14. PubMed ID: 17597264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.
    Xu Y; Wang Y; Tan Y; Zhang H; Wu L; Wang L; Hou Q; Zhang S
    BMC Microbiol; 2009 Dec; 9():274. PubMed ID: 20040101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.
    Stenger RM; Poelen MC; Moret EE; Kuipers B; Bruijns SC; Hoogerhout P; Hijnen M; King AJ; Mooi FR; Boog CJ; van Els CA
    Infect Immun; 2009 Feb; 77(2):896-903. PubMed ID: 19015250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
    Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
    Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin.
    Hussein AH; Davis EM; Halperin SA; Lee SF
    Infect Immun; 2007 Nov; 75(11):5476-82. PubMed ID: 17724067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 19. Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.
    Carriquiriborde F; Martin Aispuro P; Ambrosis N; Zurita E; Bottero D; Gaillard ME; Castuma C; Rudi E; Lodeiro A; Hozbor DF
    Front Immunol; 2021; 12():730434. PubMed ID: 34603306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.